文献速递术前评估与围术期医学疼痛医学

术前已植入阿片类鞘内给药系统患者围术期阿片消耗与临床结局

Perioperative Opioid Consumption and Clinical Outcomes in Surgical Patients With a Pre-existing Opioid-Based Intrathecal Drug Delivery System.
PubMed 文献 · Anesth Analg · 2022-01-01

BACKGROUND: Intrathecal drug delivery systems (IDDS) have been utilized for over 3 decades for management of chronic pain and spasticity.…

要点

  • IDDS患者围术期阿片消耗更高,术后24/72小时分别增2.23/2.46倍
  • IDDS患者术后疼痛科会诊率显著更高(51.8% vs 6.2%)
  • 氧需求升级、纳洛酮使用、疼痛-镇静不匹配无显著差异

核心结论

  • IDDS患者围术期阿片消耗更高,术后疼痛科会诊更频繁,但临床安全结局无显著差异。

研究设计与样本

  • 2007年1月1日至2016年12月31日的历史匹配队列研究,纳入IDDS患者与匹配对照,排除介入性疼痛操作。
  • 共321例手术,IDDS组112例,对照组209例,中位年龄57(IQR 49-64)岁,IDDS组按1:2匹配无IDDS患者。

主要发现

  • 术后氧需求升级、纳洛酮使用、疼痛-镇静不匹配无显著差异。

临床怎么用

  • 对IDDS患者围术期应预期更高阿片需求,并提前安排疼痛科会诊。
  • IDDS患者可能对较高阿片剂量耐受,安全结局无显著差异,但仍需个体化评估。

局限性

  • 原文未明确列出局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrathecal drug delivery systems (IDDS) have been utilized for over 3 decades for management of chronic pain and spasticity. Patients with IDDS may present for surgical procedures unrelated to the IDDS device, although data are limited regarding perioperative outcomes. METHODS: This is a historical matched cohort study conducted between January 1, 2007 and December 31, 2016 of patients with an opioid-based IDDS versus matched control patients undergoing surgery excluding interventional pain procedures. Patients in the IDDS group were matched with up to 2 patients without an IDDS. Multivariable regression analyses were utilized to assess differences in the primary outcome of cumulative perioperative opioid consumption (ie, intraoperative and postanesthesia care unit [PACU] opioid consumption), and opioid consumption during the first 24 and 72 postoperative hours. Postoperative clinical outcomes were also assessed including escalating oxygen requirements, naloxone administration, pain-sedation mismatch, and perioperative pain service consultation. RESULTS: A total of 321 surgeries were included, 112 with IDDS and 209 controls, with median (interquartile range [IQR]) age of 57 (49-64) years. Compared to matched controls, patients with an IDDS had greater perioperative opioid consumption (median [IQR] oral morphine milligram equivalents [OME] of 110 [60-163] vs 93 [IQR, 53-142]; adjusted multiplicative increase 1.28 [95% confidence interval {CI}, 1.03-1.59]; P = .026). IDDS patients also had greater opioid consumption in the first 24 and 72 postoperative hours (multiplicative increases of 2.23 [95% CI, 1.36-3.63], P = .001, and 2.46 [95% CI, 1.41-4.32], P = .002, respectively). There were no significant differences in postoperative oxygen requirements, naloxone administration, or pain-sedation mismatch. Inpatient pain medicine consultation was more frequent in IDDS patients compared to controls (51.8% vs 6.2%; P < .001). CONCLUSIONS: Patients with opioid-based IDDS received more perioperative opioids and were more likely to receive postoperative pain service consultation compared to matched controls. There were no significant differences in clinical safety outcomes, suggesting tolerance for higher opioid doses. Further research is warranted to optimize perioperative outcomes in those with IDDS.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. D'Souza RS, Warner MA, Olatoye OO, et al. Perioperative Opioid Consumption and Clinical Outcomes in Surgical Patients With a Pre-existing Opioid-Based Intrathecal Drug Delivery System. Anesth Analg. 2022. PMID: 34260427. doi:10.1213/ANE.0000000000005662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。